MedPath

Evaluation of intrauterine gel of mazo aqueous extract on postpartum hemorrhage

Phase 3
Conditions
postpartum hemorrhage.
Postpartum hemorrhage
Registration Number
IRCT20210305050583N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
68
Inclusion Criteria

Persian has informed consent to participate in the study .
Tends to have a normal delivery.
Have a singleton pregnancy with a display of the peak of the head
Maternal body mass index is less than 30
Mathers have no history of anemia HB<7
Has no history of allergies to herbal medicines.
Has no history of medical and obstetric diseases.
Has no history of cesarean section and uterine surgery.
Has a history of giving birth less than 5 times .
Gestational age is between 37-42 weeks and in the active phase labore (4-6cm)
Fetal weight should be estimated between 2500-4000
Water bag rupture should not be more than 12 hours and temperature should not be more than 38

Exclusion Criteria

Persion dose not want to continue participating in the study.
Delivery by cesarean section.
Grade 3or 4 perineal rupture or rupture of uterus and cervix occur.
Quick deliveries.
Have delivery with the device.
Have postpartum hemorrhage more than 500cc.
Placenta out by hand

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postpartum hemorrhage. Timepoint: At the beginning of the intervention, at the end of the first, second, third, fourth and first four hours after delivery. Method of measurement: By weighing the method of collecting blood bags and disposable drums and pads.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath